
Join to View Full Profile
9500 Euclid aveCleveland, OH 44195
Dr. Bukavina is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Laura Bukavina, MD, located in Cleveland, OH, specializes in urology and completed her residency at Case Western Reserve University/University Hospitals Cleveland Medical Center from 2016 to 2021. She earned her MD from Northeast Ohio Medical University in 2013 and her MPH in Epidemiology from Johns Hopkins Bloomberg School of Public Health between 2012 and 2015. Dr. Bukavina has experience in treating conditions such as urothelial carcinoma, adrenal neoplasms, kidney cancer, bladder cancer, and penile cancer. Her recent publications include research on topics like reconstructive urologic surgery, the microbiome in bladder cancer, and prognostic models for tumor microenvironment-associated genes. Her work has been featured in journals such as Urology, Urologic Oncology, JCO Precision Oncology, European Urology Oncology, and JCO Oncology Practice.
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Urology, 2016 - 2021
- NCIFellowship, 2014 - 2015
- Johns Hopkins Bloomberg School of Public HealthMPH, Epidemiology, 2012 - 2015
- Northeast Ohio Medical UniversityClass of 2013, MD
Certifications & Licensure
- OH State Medical License 2015 - 2027
- PA State Medical License 2021 - 2026
- NJ State Medical License 2022 - 2023
Publications & Presentations
PubMed
- Real-World Experience with a Commercial Circulating Tumor DNA Assay in Non-muscle-invasive Bladder Cancer.Betty Wang, Laura E Davis, Christopher J Weight, Robert Abouassaly, Laura Bukavina
European Urology Oncology. 2025-06-13 - Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer, a study with 5-year follow-up: a plain language summary.Betty Wang, Christopher Weight, Adam Calaway, Robert Abouassaly, Andres Correa
Future Oncology. 2025-06-01 - Beyond Citations: Exploring Gender and Racial Gaps in Urology Publications Through Citation and Altmetric Analysis.Betty Wang, Devika Nandwana, Emma Helstrom, Laura E Davis, Kirtishri Mishra
Urology. 2025-05-24
Press Mentions
- Bladder Cancer Patients’ Microbiomes Can Influence How Chemotherapy Is MetabolizedMay 2nd, 2025
- Three Kidney Cancer Experts to Receive Awards at 2024 IKCS: North AmericaSeptember 27th, 2024
- Anti-PD-1 in BCG-Unresponsive Papillary Bladder TumorsMay 22nd, 2023
- Join now to see all
Grant Support
- Microbiome in Bladder CancerCase Western Comprehensive Cancer CenterPresent
- Hormal Pathways In Bladder CancerCase Western/SPOREPresent
Professional Memberships
- Women in Urologic OncologyMember
- Society of Women in UrologyMember
- American Urologic AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: